Dr. Burns is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 W 10th Ave
Columbus, OH 43210Phone+1 614-293-5066Fax+1 614-293-9449
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011- Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2008
Perelman School of Medicine at the University of PennsylvaniaClass of 2005
Certifications & Licensure
OH State Medical License 2024 - 2026
PA State Medical License 2012 - 2024
MD State Medical License 2008 - 2012- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Detection of Genetic Markers of Lung Cancer Start of enrollment: 1996 Jun 01
- Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer Start of enrollment: 2013 Sep 01
- A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours Start of enrollment: 2024 Jun 28
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Corrigendum to "Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells" [Neoplasia 17 (2014) 85].Rajendra P Gajula, Sivarajan T Chettiar, Russell D Williams, Katriana Nugent, Yoshinori Kato
Neoplasia. 2024-11-01 - CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma.Suet Kee Loo, Gabriel Sica, Xian Wang, Tingting Li, Luping Chen
Cell & Bioscience. 2024-10-09 - The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases.Xiancheng Wu, Laura P Stabile, Timothy F Burns
Clinical Lung Cancer. 2024-09-01
Press Mentions
Taking on Acquired Resistance in EGFR-Mutant NSCLCNovember 1st, 2024- FDA Approves Amgen Drug for Permanently Fatal Form of Lung CancerMay 16th, 2024
- Lung Cancer Survival Rate in Pennsylvania Improves, Report ShowsNovember 15th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
